Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2003
09/04/2003US20030165844 Haplotypes of the TNFRSF1A gene
09/04/2003US20030165843 Microarray for profiling gene expression in cells and tissues; antisense agents; antitumor agents
09/04/2003US20030165840 Comprises replication of oligonucleotides for detection, diagnosis and treatment of cancer using 5-Fluorouracil-based chemotherapeutic regimen
09/04/2003US20030165839 Screening chemical compounds for use as antitumor agents; apoptosis-inducing agent; tumor suppressor gene
09/04/2003US20030165837 Method for screening DNA binding
09/04/2003US20030165836 Using computer and allelic marker for mapping genetic disorder to preferential region on chromosome
09/04/2003US20030165834 Using colon cancer associated polypeptides (CCP) for diagnosing and detecting rectal tumors; immunoassays
09/04/2003US20030165833 Hybridization probes and oligonucleotides used for quantitative analysis fo ribosomal nucleic acids from yeast
09/04/2003US20030165832 Genetic replication of DNA contained in samples, then detecting and analyzing using fluorescent resonance energy transfer(FRET) hybridization probes, in kits; quantitative analysis
09/04/2003US20030165831 Comprise nucleotide sequences for diagnosing and treating gynecological tumors; antitumor/anticarcinogenic agents
09/04/2003US20030165830 Arrays of nucleic acid probes for analyzing biotransformation genes
09/04/2003US20030165828 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions
09/04/2003US20030165827 Screening for point mutations in complementary determining regions of DNA; medical diagnosis
09/04/2003US20030165826 PG-3 and biallelic markers thereof
09/04/2003US20030165824 Diagnosis and analysis of grampositive bacteria using kits containing oligonucleotides, polymerases, primers and/or mixtures, used for genetic replication of ribosomal RNA sequences or DNA codes
09/04/2003US20030165823 Comprises oligonucleotide sequences immobilized in microfabricated patterns on matrix for analyzing cystic fibrosis transmembrane conductance regulator (CFTR) gene
09/04/2003US20030165821 Detection and identification of human papillomavirus by PCR and type-specific reverse hybridization
09/04/2003US20030165817 Diagnostic assay
09/04/2003US20030165815 Method and kit for evaluation of hiv mutations
09/04/2003US20030165814 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with CD antigens; animal husbandry
09/04/2003US20030165812 Process for sorting motile particles from lesser-motile particles and apparatus suitable therefor
09/04/2003US20030165811 Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity
09/04/2003US20030165809 MARKs as modifiers of the p53 pathway and methods of use
09/04/2003US20030165808 Identifying culture medium components using total charge, molecular weight, isoelectric point, total dipole moment, isotropic surface area, electronic charge index and hydrophobicity
09/04/2003US20030165807 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
09/04/2003US20030165806 Comprises transport protein with four transmenbrane domains for modulating heart activity; drug screening
09/04/2003US20030165578 Regulation of wound healing by nitric oxide
09/04/2003US20030165540 Sentinel virus II
09/04/2003US20030165538 Vaccines, biocatalyst; supplying to respiratory system, mucous membrane; modulate immunology response; fusion protein with spore overcoatings
09/04/2003US20030165510 Antiinflammatory agents; anticancer agents; cholesterol binding protein
09/04/2003US20030165506 Novel alpha-catenin expressed in heart and testis
09/04/2003US20030165505 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
09/04/2003US20030165500 Antiproliferative agents; proteins; signal passageways; anticancer agents
09/04/2003US20030165497 RRP sequences and knockout mice and uses thereof
09/04/2003US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis
09/04/2003US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering
09/04/2003US20030165490 22196, a novel human aminopeptidase
09/04/2003US20030165429 Method for measuring skin absorbability of a substance
09/04/2003US20030164449 Method for analysing enzyme-catalysed reactions using maldi-tof mass spectrometry
09/04/2003DE20306138U1 Preparation of biological target cells, with auxiliary erythrocytes, has a glass carrier for use with a multi-beam laser as optical tweezers for manipulation to examine the cell elasticity
09/04/2003CA2696267A1 Methods for preventing or treating cardiac arrhythmia
09/04/2003CA2480320A1 Analysis of mixtures of nucleic acid fragments and of gene expression
09/04/2003CA2477574A1 Melting temperature dependent dna amplification
09/04/2003CA2477573A1 Headloop dna amplification
09/04/2003CA2477519A1 Method of error reduction in nucleic acid populations
09/04/2003CA2477503A1 Surface modification, linker attachment, and polymerization methods
09/04/2003CA2477443A1 Sterility testing apparatus
09/04/2003CA2477417A1 Methods and products based on oligomerization of stress proteins
09/04/2003CA2477317A1 Holding tray having through-hole wells
09/04/2003CA2477309A1 Screening process
09/04/2003CA2477295A1 Trans-splicing mediated imaging of gene expression
09/04/2003CA2477283A1 Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes
09/04/2003CA2477271A1 Nanostructures containing pilin protein
09/04/2003CA2477270A1 Nanostructures containing antibody assembly units
09/04/2003CA2477253A1 Compositions and method for regulation of calcium-dependent signalling in brain
09/04/2003CA2477249A1 Novel type-1 cytokine receptor glm-r
09/04/2003CA2477239A1 Drug signatures
09/04/2003CA2477225A1 Novel compositions and methods for cancer
09/04/2003CA2477171A1 Nanostructures containing pna joining or functional elements
09/04/2003CA2477170A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003CA2477111A1 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003CA2476942A1 Assay for activity of the actriib kinase
09/04/2003CA2476890A1 Subtilisin carlsberg proteins with reduced immunogenicity
09/04/2003CA2476846A1 Method for detection of leptin receptor ligands
09/04/2003CA2476790A1 Population based assessments and means to rank the relative immunogenicity of proteins
09/04/2003CA2476661A1 Method for generating amplified rna
09/04/2003CA2476571A1 Method for isolating ligands
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2476481A1 Recombinase polymerase amplification
09/04/2003CA2476480A1 Methods of making hypermutable cells using pmsr homologs
09/04/2003CA2475680A1 Method for in vitro detection of cancers by highlighting allelic imbalances in insertion/deletion markers
09/04/2003CA2474751A1 Expression system for human brain-specific voltage-gated sodium channel, type 1
09/04/2003CA2474700A1 Molecular diagnosis and prognosis of carcinomas
09/04/2003CA2472554A1 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same
09/04/2003CA2467836A1 Interfacial biomaterials
09/04/2003CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/04/2003CA2457907A1 Stain-directed molecular analysis for cancer prognosis and diagnosis
09/04/2003CA2451982A1 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
09/03/2003EP1340979A2 Neuropeptide receptor and uses thereof
09/03/2003EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340819A1 Microsatellite markers
09/03/2003EP1340818A1 Method and nucleic acids for the analysis of a colon cell proliferative disorder
09/03/2003EP1340817A1 Assay for activity of the actRIIB kinase
09/03/2003EP1340816A2 Quantitation of individual protein kinase activity
09/03/2003EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity
09/03/2003EP1340812A2 Functional domains in flavobacterium okeanokoites (Foki) restriction endonuclease
09/03/2003EP1340764A2 Nucleic acid mediated electron transfer
09/03/2003EP1340544A1 Biochip including carbon nanotubes and method for sample separation using the same
09/03/2003EP1340088A2 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
09/03/2003EP1340084A2 Proteins, genes and their use for diagnosis and treatment of chronic asthma
09/03/2003EP1340082A2 Microfluidic device and method with transport of magnetic particles into and out of wells
09/03/2003EP1340080A2 Membrane molecule indicator compositions and methods
09/03/2003EP1340079A2 S. aureus protein staau-r2, gene encoding it and uses thereof
09/03/2003EP1340075A2 Establishment of biological cut-off values for predicting resistance to therapy
09/03/2003EP1339879A2 Method of identifying a polymorphism in cyp2d6
09/03/2003EP1339878A2 Method for identifying modulators of transcription
09/03/2003EP1339877A1 Isothermal amplification of nucleic acids on a solid support
09/03/2003EP1339876A2 Purification of dna sequencing reactions using silica magnetic particles
09/03/2003EP1339873A2 Diagnosis of diseases associated with the human c-mos gene
1 ... 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 ... 3003